Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
10
Number of overlapping holdings
24.4%
% of MNTL's 44 holdings also in SBIO
11.8%
% of SBIO's 90 holdings also in MNTL
Overlap by Weight
Sector Drift (MNTL minus SBIO)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in MNTL |
Weight in SBIO |
Overlap | |
|---|---|---|---|---|
 |
CRINETICS PHARMACEUTICALS INC | 4.2% | 2.7% | 2.7% |
|
AXSOME THERAPEUTICS, INC. | 2.6% | 4.4% | 2.6% |
|
DENALI THERAPEUTICS INC. | 2.0% | 1.9% | 1.9% |
 |
ALKERMES PLC | 1.7% | 4.1% | 1.7% |
|
ACADIA PHARMACEUTICALS INC | 1.7% | 2.3% | 1.7% |
Position Highlights (Non-Overlapping Exposures)
MNTL Overweight Relative to SBIO
|
VERTEX PHARMACEUTICALS INC | 11.9% |
|
REGENERON PHARMACEUTICALS | 7.7% |
 |
ARGENX SE ADR | 5.6% |
|
ALNYLAM PHARMACEUTICALS INC | 4.9% |
|
ELI LILLY & CO | 4.9% |
|
NEUROCRINE BIOSCIENCES INC | 4.2% |
 |
TEVA PHARMACEUTICAL-SP ADR | 4.2% |
|
BIOGEN IDEC INC | 3.1% |
|
STRYKER CORP | 2.9% |
|
CATALYST PHARMACEUTICAL PART | 2.7% |
MNTL Underweight Relative to SBIO
|
RHYTHM PHARMACEUTICALS, INC. | -3.8% |
 |
ZAI LAB LTD. UNSPONSORED ADR | -2.9% |
 |
MERUS N.V. | -2.9% |
|
AKERO THERAPEUTICS, INC. | -2.9% |
|
PROTAGONIST THERAPEUTICS, INC. | -2.8% |
|
ALKERMES PLC | -2.4% |
 |
MOONLAKE IMMUNOTHERAPEUTICS CLASS A | -2.4% |
|
PTC THERAPEUTICS INC | -2.0% |
|
AMICUS THERAPEUTICS INC | -2.0% |
|
VERICEL CORPORATION | -2.0% |